REPOSITORY ID,REPOSITORY LINK,SAMPLE NUMBER,STUDY TITLE,STUDY LINK,ASSAY TYPE,TECHNOLOGY,COUNTRY,DISEASE,DOID,STUDY DESIGN,BODY SITE,PLATFORM,PARTICIPANT FEATURES,AVERAGE SPOTLENGTH,RUN ID,Sample ID,Sample Name,COLLECTION DATE,LIBRARY LAYOUT,LAT LON,SAMPLE TYPE,ETHNICITY,ELO,URBANZATION,REGION,CITYVILLAGE,TARGET AMPLICON,DIET
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,HCV,1883,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889523,SRS1560514,hcv_GM__AMA_P1_R1,02/22/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,HCV,1883,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889524,SRS1560515,hcv_GM__AMA_P1_R2,02/22/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,HCV,1883,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889525,SRS1560516,hcv_GM__AMA_P6_R1,02/22/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,HCV,1883,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889526,SRS1560517,hcv_GM__AMA_P6_R2,02/22/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889527,SRS1560518,Healthy_GM_AMA_H1_R1,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889528,SRS1560519,Healthy_GM_AMA_H1_R2,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889529,SRS1560520,Healthy_GM_AMA_H2_R1,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889530,SRS1560521,Healthy_GM_AMA_H2_R2,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889531,SRS1560522,Healthy_GM_AMA_H3_R1,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889532,SRS1560523,Healthy_GM_AMA_H3_R2,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889533,SRS1560524,Healthy_GM_AMA_H4_R1,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889534,SRS1560525,Healthy_GM_AMA_H4_R2,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,HCV,1883,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889535,SRS1560526,hcv_GM__AMA_P2_R1,02/22/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889536,SRS1560527,Healthy_GM_AMA_H5_R1,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889537,SRS1560528,Healthy_GM_AMA_H5_R2,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889538,SRS1560529,Healthy_GM_AMA_H6_R1,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889539,SRS1560532,Healthy_GM_AMA_H6_R2,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889540,SRS1560530,Healthy_GM_AMA_H7_R1,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889541,SRS1560531,Healthy_GM_AMA_H7_R2,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889542,SRS1560533,Healthy_GM_AMA_H8_R1,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,Healthy,,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889543,SRS1560534,Healthy_GM_AMA_H8_R2,05/05/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,HCV,1883,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889544,SRS1560535,hcv_GM__AMA_P2_R2,02/22/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,HCV,1883,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889545,SRS1560536,hcv_GM__AMA_P3_R1,02/22/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,HCV,1883,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889546,SRS1560537,hcv_GM__AMA_P3_R2,02/22/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,HCV,1883,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889547,SRS1560538,hcv_GM__AMA_P4_R1,02/22/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,HCV,1883,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889548,SRS1560539,hcv_GM__AMA_P4_R2,02/22/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,HCV,1883,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889549,SRS1560540,hcv_GM__AMA_P5_R1,02/22/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
PRJNA328966,PRJNA328966,28.0,Gut microbiome alterations in patients with stage 4 hepatitis c,27625705,Amplicon,Illumina,Egypt,HCV,1883,Case-control,Gut,Illumina Miseq,Adult Males  Aging Between 21 And 65,251.0,SRR3889550,SRS1560541,hcv_GM__AMA_P5_R2,02/22/2015,Paired,"29.076360, 31.097000",Stool,,,Camp,,Beni-suef,v4,
